Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity

Author(s): N. G. Abraham, P. L. Tsenovoy, J. McClung, G. S. Drummond

Journal Name: Current Pharmaceutical Design

Volume 14 , Issue 5 , 2008

Become EABM
Become Reviewer

Abstract:

Heme oxygenase-1 (HO-1) is central to the regulation of oxidative injury. The role of increased HO-1 expression and Heme oxygenase (HO) activity in mitigating the detrimental side effect of diabetes is examined. A review of the mechanism(s) of action is included. This may lead to the development of pharmacological and genetic approaches to mitigate the clinical complications associated with the progression of diabetes and obesity.

Keywords: Diabetes, Carbon monoxide, bilirubin, HO-1, Inflamation, TNF, IL-1, adiponectin

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 5
Year: 2008
Page: [412 - 421]
Pages: 10
DOI: 10.2174/138161208783597371

Article Metrics

PDF: 29